Serveur d'exploration SRAS - Exploration (Accueil)

Index « AbsEn.i » - entrée « protease »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
protagonists < protease < proteases  Facettes :

List of bibliographic references indexed by protease

Number of relevant bibliographic references: 338.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000077 (2020) Mahmoud Kandeel [Égypte] ; Mohammed Al-Nazawi [Arabie saoudite]Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease.
000092 (2020) Vineet D. Menachery [États-Unis] ; Kenneth H. Dinnon [États-Unis] ; Boyd L. Yount [États-Unis] ; Eileen T. Mcanarney [États-Unis] ; Lisa E. Gralinski [États-Unis] ; Andrew Hale [États-Unis] ; Rachel L. Graham [États-Unis] ; Trevor Scobey [États-Unis] ; Simon J. Anthony [États-Unis] ; Lingshu Wang [États-Unis] ; Barney Graham [États-Unis] ; Scott H. Randell [États-Unis] ; W Ian Lipkin [États-Unis] ; Ralph S. Baric [États-Unis]Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection.
000151 (2020) Peter P. Liu [Canada] ; Alice Blet [France] ; David Smyth [Canada] ; Hongliang Li [République populaire de Chine]The Science Underlying COVID-19: Implications for the Cardiovascular System.
000185 (2020) Rameez Jabeer Khan [Inde] ; Rajat Kumar Jha [Inde] ; Gizachew Muluneh Amera [Inde] ; Monika Jain [Inde] ; Ekampreet Singh [Inde] ; Amita Pathak [Inde] ; Rashmi Prabha Singh [Inde] ; Jayaraman Muthukumaran [Inde] ; Amit Kumar Singh [Inde]Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase.
000199 (2020) Jian Shang [États-Unis] ; Yushun Wan [États-Unis] ; Chang Liu [États-Unis] ; Boyd Yount [États-Unis] ; Kendra Gully [États-Unis] ; Yang Yang [États-Unis] ; Ashley Auerbach [États-Unis] ; Guiqing Peng [République populaire de Chine] ; Ralph Baric [États-Unis] ; Fang Li [États-Unis]Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry.
000282 (2020) Markus Hoffmann [Allemagne] ; Hannah Kleine-Weber [Allemagne] ; Simon Schroeder [Allemagne] ; Nadine Krüger [Allemagne] ; Tanja Herrler [Allemagne] ; Sandra Erichsen [Autriche] ; Tobias S. Schiergens [Allemagne] ; Georg Herrler [Allemagne] ; Nai-Huei Wu [Allemagne] ; Andreas Nitsche [Allemagne] ; Marcel A. Müller [Russie] ; Christian Drosten [Allemagne] ; Stefan Pöhlmann [Allemagne]SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
000366 (2020) Boris Krichel ; Sven Falke ; Rolf Hilgenfeld ; Lars Redecke ; Charlotte UetrechtProcessing of the SARS-CoV pp1a/ab nsp7–10 region
000380 (2020) Yu Wai Chen [Hong Kong] ; Chin-Pang Bennu Yiu [Hong Kong] ; Kwok-Yin Wong [Hong Kong]Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates
000469 (2020) Hasanain Abdulhameed Odhar [Iraq] ; Salam Waheed Ahjel [Iraq] ; Ali A. Mohammed Ali Albeer [Iraq] ; Ahmed Fadhil Hashim [Iraq] ; Ali Mahmood Rayshan [Iraq] ; Suhad Sami Humadi [Iraq]Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus
000575 (2020) Salman Ali Khan [Pakistan] ; Komal Zia [Pakistan] ; Sajda Ashraf [Pakistan] ; Reaz Uddin [Pakistan] ; Zaheer Ul-Haq [Pakistan]Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach.
000577 (2020) Marina Macchiagodena ; Marco Pagliai ; Piero ProcacciIdentification of Potential Binders of the Main Protease 3CLpro of the COVID-19 via Structure-Based Ligand Design and Molecular Modeling
000619 (2020) Michael Letko [États-Unis] ; Andrea Marzi [États-Unis] ; Vincent Munster [États-Unis]Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.
000799 (2020) Miguel Angel Martinez [Espagne]Compounds with therapeutic potential against novel respiratory 2019 coronavirus.
000997 (2020) Canrong Wu [République populaire de Chine] ; Yang Liu [République populaire de Chine] ; Yueying Yang [République populaire de Chine] ; Peng Zhang [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Yali Wang [République populaire de Chine] ; Qiqi Wang [République populaire de Chine] ; Yang Xu [République populaire de Chine] ; Mingxue Li [République populaire de Chine] ; Xingzhou Li [République populaire de Chine] ; Mengzhu Zheng [République populaire de Chine] ; Lixia Chen [République populaire de Chine] ; Hua Li [République populaire de Chine]Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
000A85 (2019) Naoko Iwata-Yoshikawa [Japon] ; Tadashi Okamura [Japon] ; Yukiko Shimizu [Japon] ; Hideki Hasegawa [Japon] ; Makoto Takeda [Japon] ; Noriyo Nagata [Japon]TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection.
000B14 (2019) Brittney D. Gimza [États-Unis] ; Maria I. Larias [États-Unis] ; Bridget G. Budny [États-Unis] ; Lindsey N. Shaw [États-Unis]Mapping the Global Network of Extracellular Protease Regulation in Staphylococcus aureus
000B18 (2019) Seri Jo ; Suwon Kim ; Dong Hae Shin ; Mi-Sun KimInhibition of SARS-CoV 3CL protease by flavonoids
000B45 (2019) Kouji Ohnishi [Japon] ; Yasunao Hattori [Japon] ; Kazuya Kobayashi [Japon] ; Kenichi Akaji [Japon]Evaluation of a non-prime site substituent and warheads combined with a decahydroisoquinolin scaffold as a SARS 3CL protease inhibitor.
000B85 (2019) Kuo-Chen Chou [République populaire de Chine]An insightful recollection since the distorted key theory was born about 23 years ago.
000C18 (2018) Daniela Niemeyer [Allemagne] ; Kirstin Mösbauer [Allemagne] ; Eva M. Klein [Allemagne] ; Andrea Sieberg [Allemagne] ; Robert C. Mettelman [États-Unis] ; Anna M. Mielech [États-Unis] ; Ronald Dijkman [Suisse] ; Susan C. Baker [États-Unis] ; Christian Drosten [Allemagne] ; Marcel A. Müller [Allemagne]The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species
000C32 (2018) Liangzhong Lim [Singapour] ; Garvita Gupta [Singapour] ; Amrita Roy [Singapour] ; Jian Kang [Singapour] ; Shagun Srivastava [Singapour] ; Jiahai Shi ; Jianxing Song [Singapour]Structurally- and dynamically-driven allostery of the chymotrypsin-like proteases of SARS, Dengue and Zika viruses

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "protease" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "protease" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    protease
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021